Admelog Solostar
Brand for: Insulin lispro (1 unit dial)
My Prescription
Payment
Select pharmacy
$33.22
Print or send this coupon to your phone
AlbertsonsPowered byAbout Admelog Solostar
Drug Details
Insulin lispro is a medication designed to manage high blood sugar levels in individuals with diabetes when used alongside a suitable diet and exercise regimen. By effectively controlling blood sugar, it helps prevent complications such as kidney damage, vision loss, nerve issues, limb amputations, and sexual dysfunction. Additionally, well-managed diabetes can reduce the risk of heart attacks and strokes. Insulin lispro is a synthetic version of insulin, acting more rapidly and for a shorter duration than regular insulin. It facilitates the entry of glucose into cells, allowing the body to utilize it for energy. Typically, insulin lispro is used in conjunction with medium- or long-acting insulin and may also be combined with oral diabetes medications, such as sulfonylureas like glyburide or glipizide.
Admelog Solostar (Insulin Lispro (1 Unit Dial)) dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 3ML of 100UNIT/ML | 1 Pen | $43.65 | $43.65 |
| 3ML of 100UNIT/ML | 2 Pens | $75.14 | $37.57 |
| 3ML of 100UNIT/ML | 3 Pens | $105.70 | $35.23 |
Admelog Solostar FAQs
ADMELOG Solostar is a rapid-acting insulin.
ADMELOG SoloStar and NovoLog are both rapid-acting insulin analogs used to control blood sugar levels in individuals with diabetes. However, they are not the same. ADMELOG contains insulin lispro, while NovoLog contains insulin aspart. Both are used to manage blood glucose levels around meal times, but they are different formulations and may have different onset and duration of action. It is important for patients to follow their healthcare provider's instructions regarding which insulin to use.
ADMELOG is classified as a rapid-acting insulin.
Humalog and ADMELOG are both rapid-acting insulin analogs used to control blood sugar levels in individuals with diabetes. The primary difference between the two is that Humalog is the original brand, while ADMELOG is a biosimilar. A biosimilar is a medication that is highly similar to an already approved biologic product, with no clinically meaningful differences in terms of safety, purity, and potency. Both insulins have similar onset, peak, and duration of action, and they are used in similar ways to manage blood glucose levels.
ADMELOG is a short-acting insulin.